Diabetes de tipo 2 en niños

American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025 Jan;48(suppl 1):S1-352.Texto completo

Shah AS, Barrientos-Pérez M, Chang N, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-83.Texto completo  Resumen

Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-56. Resumen

1. American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025 Jan;48(suppl 1):S1-352.Texto completo

2. Shah AS, Barrientos-Pérez M, Chang N, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-83.Texto completo  Resumen

3. Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016 May 27;118(11):1723-35.Texto completo  Resumen

4. Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-56. Resumen

5. Kaufman FR, Shaw J. Type 2 diabetes in youth: rates, antecedents, treatment, problems and prevention. Pediatr Diabetes. 2007 Dec;8(suppl 9):4-6. Resumen

6. Diabetes Australia Guideline Development Consortium. National evidence based guideline for case detection and diagnosis of type 2 diabetes. Jun 2009 [internet publication].Texto completo

7. Centers for Disease Control and Prevention. National diabetes statistics report: diabetes. May 2024 [internet publication].Texto completo

8. Misra S, Ke C, Srinivasan S, et al. Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol. 2023 Oct;11(10):768-82. Resumen

9. Xie J, Wang M, Long Z, et al. Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019. BMJ. 2022 Dec 7;379:e072385.Texto completo  Resumen

10. Centers for Disease Control and Prevention. National diabetes statistics report​: diabetes. May 2024 [internet publication].Texto completo

11. NHS England. Children and young people diabetes toolkit. Jul 2024 [internet publication].Texto completo

12. Savage PJ, Bennett PH, Senter RG, et al. High prevalence of diabetes in young Pima Indians. Diabetes. 1979 Oct;28(10):937-42. Resumen

13. Lascar N, Brown J, Pattison H, et al. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2017 Aug 25;6(1):69-80.Texto completo  Resumen

14. Acton KJ, Burrows NR, Moore K, et al. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health. 2002 Sep;92(9):1485-90.Texto completo  Resumen

15. Gahagan S, Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics Committee on Native American Child Health. Pediatrics. 2003 Oct;112(4):e328.Texto completo  Resumen

16. Lawrence JM, Divers J, Isom S, et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA. 2021 Aug 24;326(8):717-27.Texto completo  Resumen

17. Perng W, Conway R, Mayer-Davis E, et al. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care. 2023 Mar 1;46(3):490-9.Texto completo  Resumen

18. Arslanian S, Bacha F, Grey M, et al. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. Diabetes Care. 2018 Dec;41(12):2648-2668.Texto completo  Resumen

19. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008 May 28;299(20):2401-5.Texto completo  Resumen

20. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005 May;146(5):693-700. Resumen

21. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA. 2001 Dec 12;286(22):2845-8.Texto completo  Resumen

22. Haines L, Wan KC, Lynn R, et al. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care. 2007 May;30(5):1097-101.Texto completo  Resumen

23. Miller J, Rosenbloom A, Silverstein J. Childhood obesity. J Clin Endocrinol Metab. 2004 Sep;89(9):4211-8.Texto completo  Resumen

24. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011 Jul 9;378(9786):169-81. Resumen

25. Ornoy A. Prenatal origin of obesity and its complication: gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol. 2011 Sep;32(2):205-12. Resumen

26. Diabetes UK. Type 2 diabetes in children and young people. Aug 2024 [internet publication].Texto completo

27. Cioana M, Deng J, Nadarajah A, et al. The prevalence of obesity among children with type 2 diabetes: a systematic review and meta-analysis. JAMA Netw Open. 2022 Dec 1;5(12):e2247186.Texto completo  Resumen

28. Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003 Aug 18;92(4a):10J-7J. Resumen

29. Foster GD, Linder B, Baranowski T, et al; HEALTHY Study Group. A school-based intervention for diabetes risk reduction. N Engl J Med. 2010 Jul 29;363(5):443-53.Texto completo  Resumen

30. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000 Dec;49(12):2208-11.Texto completo  Resumen

31. Ibáñez L, Suárez L, Lopez-Bermejo A, et al. Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight. J Clin Endocrinol Metab. 2008 Mar;93(3):925-8. Resumen

32. Ibáñez L, Ong K, Dunger DB, et al. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab. 2006 Jun;91(6):2153-8. Resumen

33. Mericq V, Ong KK, Bazaes R, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia. 2005 Dec;48(12):2609-14. Resumen

34. Mayer-Davis EJ, Dabelea D, Lamichhane AP, et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCH for diabetes in youth case-control study. Diabetes Care. 2008 Mar;31(3):470-5.Texto completo  Resumen

35. Koletzko B. Long-term consequences of early feeding on later obesity risk. Nestle Nutr Workshop Ser Pediatr Program. 2006;58:1-18. Resumen

36. Arslanian S, Bacha F, Grey M, et al. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care. 2018 Dec;41(12):2648-68.Texto completo

37. Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in children and adolescents. Curr Diabetes Rev. 2020;16(3):220-9.Texto completo  Resumen

38. Kelsey MM, Zeitler PS. Insulin resistance of puberty. Curr Diab Rep. 2016 Jul;16(7):64. Resumen

39. Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:509-17. Resumen

40. Hanis CL, Boerwinkle E, Chakraborty R. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet. 1996 Jun;13(2):161-6. Resumen

41. Copeland KC, Zeitler P, Geffner M, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011 Jan;96(1):159-67.Texto completo  Resumen

42. Srinivasan S, Chen L, Todd J, et al. The first genome-wide association study for type 2 diabetes in youth: the progress in diabetes genetics in youth (ProDiGY) Consortium. Diabetes. 2021 Apr;70(4):996-1005.Texto completo  Resumen

43. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021 May;137:111315.Texto completo  Resumen

44. Lee S, Bacha F, Gungor N, et al. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008 Feb;152(2):177-84. Resumen

45. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006 Nov;2(4):367-73. Resumen

46. Straczkowski M, Kowalska I. The role of skeletal muscle sphingolipids in the development of insulin resistance. Rev Diabet Stud. 2008 Spring;5(1):13-24.Texto completo  Resumen

47. Yamamoto JM, Prado-Núñez S, Guarnizo-Poma M, et al. Association between serum transaminase levels and insulin resistance in euthyroid and non-diabetic adults. Diabetes Metab Syndr. 2020 Jan-Feb;14(1):17-21. Resumen

48. Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;2020:3920196.Texto completo  Resumen

49. Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023 Nov 14;148(20):1606-35.Texto completo  Resumen

50. Zheng M, Lamb KE, Grimes C, et al. Rapid weight gain during infancy and subsequent adiposity: a systematic review and meta-analysis of evidence. Obes Rev. 2018 Mar;19(3):321-32.Texto completo  Resumen

51. Arnesen EK, Thorisdottir B, Lamberg-Allardt C, et al. Protein intake in children and growth and risk of overweight or obesity: a systematic review and meta-analysis. Food Nutr Res. 2022;66.Texto completo  Resumen

52. Cioana M, Deng J, Nadarajah A, et al. Prevalence of polycystic ovary syndrome in patients with pediatric type 2 diabetes: a systematic review and meta-analysis. JAMA Netw Open. 2022 Feb 1;5(2):e2147454.Texto completo  Resumen

53. Kings College London. Onset and care of type 2 diabetes mellitus in people with a learning disability. 2022 [internet publication].Texto completo

54. Taggart L, Coates V, Truesdale-Kennedy M. Management and quality indicators of diabetes mellitus in people with intellectual disabilities. J Intellect Disabil Res. 2013 Dec;57(12):1152-63. Resumen

55. NHS England. ​National diabetes audit 2021-22, report 1: care processes and treatment targets, detailed analysis report. Oct 2023 [internet publication].Texto completo

56. Ogata BN, Hayes D. Position of the Academy of Nutrition and Dietetics: nutrition guidance for healthy children ages 2 to 11 years. J Acad Nutr Diet. 2014 Aug;114(8):1257-76. Resumen

57. Maessen SE, Nichols M, Cutfield W, et al. High but decreasing prevalence of overweight in preschool children: encouragement for further action. BMJ. 2023 Oct 9;383:e075736.Texto completo  Resumen

58. Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017 Jun 22;(6):CD012651.Texto completo  Resumen

59. World Health Organization. ​Carbohydrate intake for adults and children: WHO guideline Jul 2023 [internet publication].Texto completo

60. Belsky N, Tamaroff J, Shoemaker AH. Risk factors for progression to type 2 diabetes in a pediatric prediabetes clinic population. J Endocr Soc. 2023 Oct 9;7(11):bvad118.Texto completo  Resumen

61. Kleber M, deSousa G, Papcke S, et al. Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):172-6. Resumen

62. Weiss R, Taksali SE, Tamborlane WV, et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005 Apr;28(4):902-9.Texto completo  Resumen

63. RISE Consortium. Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care. 2018 Aug;41(8):1717-25.Texto completo  Resumen

64. Khokhar A, Umpaichitra V, Chin VL, et al. Metformin use in children and adolescents with prediabetes. Pediatr Clin North Am. 2017 Dec;64(6):1341-53. Resumen

65. Serbis A, Giapros V, Kotanidou EP, et al. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2021 Apr 15;12(4):344-65.Texto completo  Resumen

66. Brickman WJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010 Jan;156(1):87-92. Resumen

67. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013 Jul;30(7):803-17.Texto completo  Resumen

68. Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017 Jun;8(3):475-87.Texto completo  Resumen

69. Chiang JL, Maahs DM, Garvey KC, et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018 Sep;41(9):2026-44.Texto completo  Resumen

70. Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013 Oct;98(10):4055-62.Texto completo  Resumen

71. Peixoto-Barbosa R, Reis AF, Giuffrida FMA. Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetol Metab Syndr. 2020;12:50.Texto completo  Resumen

72. Sanyoura M, Philipson LH, Naylor R. Monogenic diabetes in children and adolescents: recognition and treatment options. Curr Diab Rep. 2018 Jun 22;18(8):58. Resumen

73. Greeley SA, Naylor RN, Philipson LH, et al. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep. 2011 Dec;11(6):519-32.Texto completo  Resumen

74. Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023 Feb 1;151(2):e2022060640.Texto completo  Resumen

75. US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Screening for prediabetes and type 2 diabetes in children and adolescents: US preventive services task force recommendation statement. JAMA. 2022 Sep 13;328(10):963-7.Texto completo  Resumen

76. Viner R, White B, Christie D. Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden. Lancet. 2017 Jun 3;389(10085):2252-60. Resumen

77. Simmons D, Voyle J, Rush E, et al. The New Zealand experience in peer support interventions among people with diabetes. Fam Pract. 2010 Jun;27(suppl 1):i53-61.Texto completo  Resumen

78. Neyman A, Hannon TS, Committee on Nutrition. Low-carbohydrate diets in children and adolescents with or at risk for diabetes. Pediatrics. 2023 Oct 1;152(4):e2023063755.Texto completo  Resumen

79. Willi SM, Martin K, Datko FM, et al. Treatment of type 2 diabetes in childhood using a very-low-calorie diet. Diabetes Care. 2004 Feb;27(2):348-53.Texto completo  Resumen

80. Dela F, von Linstow ME, Mikines KJ, et al. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E1024-31.Texto completo  Resumen

81. Marwick TH, Hordern MD, Miller T, et al. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009 Jun 30;119(25):3244-62.Texto completo  Resumen

82. McCall A, Raj R. Exercise for prevention of obesity and diabetes in children and adolescents. Clin Sports Med. 2009 Jul;28(3):393-421. Resumen

83. Christie D, Strange V, Allen E, et al. Maximising engagement, motivation and long term change in a structured intensive education programme in diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE). BMC Pediatr. 2009 Sep 15;9:57.Texto completo  Resumen

84. Misra A, Nigam P, Hills AP, et al. Consensus physical activity guidelines for Asian Indians. Diabetes Technol Ther. 2012 Jan;14(1):83-98. Resumen

85. Johnson ST, Newton AS, Chopra M, et al. In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: a systematic review. BMC Pediatr. 2010 Dec 23;10:97.Texto completo  Resumen

86. TODAY Study Group; Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012 Jun 12;366(24):2247-56.Texto completo  Resumen

87. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan;32(1):193-203.Texto completo  Resumen

88. Tamborlane WV, Barrientos-Pérez M, Fainberg U, et al. Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med. 2019 Aug 15;381(7):637-46.Texto completo  Resumen

89. Tamborlane WV, Bishai R, Geller D, et al. Once-weekly exenatide in youth with type 2 diabetes. Diabetes Care. 2022 Aug 1;45(8):1833-40.Texto completo  Resumen

90. Arslanian SA, Hannon T, Zeitler P, et al. Once-weekly dulaglutide for the treatment of youths with type 2 diabetes. N Engl J Med. 2022 Aug 4;387(5):433-43.Texto completo  Resumen

91. Laffel LM, Danne T, Klingensmith GJ, et al. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-81.Texto completo  Resumen

92. Tamborlane WV, Laffel LM, Shehadeh N, et al. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. Lancet Diabetes Endocrinol. 2022 May;10(5):341-50.Texto completo  Resumen

93. Shehadeh N, Barrett T, Galassetti P, et al. Dapagliflozin or saxagliptin in pediatric type 2 diabetes. NEJM Evid. 2023 Dec;2(12):EVIDoa2300210.Texto completo  Resumen

94. McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.Texto completo  Resumen

95. National Institute for Health and Care Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes. July 2008 [internet publication].Texto completo

96. Medicines and Healthcare Products Regulatory Agency. GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued Jun 2019 [internet publication].Texto completo

97. World Gastroenterology Organisation and International Federation for the Surgery of Obesity and Metabolic Diseases. Obesity. 2023 [internet publication].Texto completo

98. Poliakin L, Roberts A, Thompson KJ, et al. Outcomes of adolescents compared with young adults after bariatric surgery: an analysis of 227,671 patients using the MBSAQIP data registry. Surg Obes Relat Dis. 2020 Oct;16(10):1463-73. Resumen

99. Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021 Aug 30;44(10):2438-44.Texto completo  Resumen

100. Inge TH, Courcoulas AP, Jenkins TM, et al. Weight loss and health status 3 Years after bariatric surgery in adolescents. N Engl J Med. 2016 Jan 14;374(2):113-23.Texto completo  Resumen

101. Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009 Jan;123(1):214-22. Resumen

102. National Institute of Health Care and Excellence. ​Diabetes (type 1 and type 2) in children and young people: diagnosis and management. May 2023 [internet publication].Texto completo

103. Shankar RR, Zeitler P, Deeb A, et al. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Pediatr Diabetes. 2022 Mar;23(2):173-82. Resumen

104. Jalaludin MY, Deeb A, Zeitler P, et al. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. Pediatr Diabetes. 2022 Mar;23(2):183-93. Resumen

105. ClinicalTrials.gov. Phase 3 alogliptin pediatric study. ClinicalTrials.gov Identifier: NCT02856113. Oct 2022 [internet publication].Texto completo

106. Adeyemi A, Rascati K, Strassels S. The need for oral antidiabetic treatment adherence studies in the pediatric population. Clin Ther. 2010 Jul;32(7):1306-7. Resumen

107. Kawahara R, Amemiya T, Yoshino M, et al. Dropout of young non-insulin-dependent diabetics from diabetic care. Diabetes Res Clin Pract. 1994 Jul;24(3):181-5. Resumen

108. TODAY Study Group, TODAY Study Group. Long-term outcomes among young adults with type 2 diabetes based on durability of glycemic control: results from the TODAY Cohort Study. Diabetes Care. 2022 Nov 1;45(11):2689-97.Texto completo  Resumen

109. Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr. 2010 Feb;156(2):180-4. Resumen

110. Abraham MB, Karges B, Dovc K, et al. ISPAD clinical practice consensus guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.Texto completo

111. Marx N, Federici M, Schütt K, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043-140.Texto completo

112. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013 Jun;36(6):1735-41.Texto completo  Resumen

113. TODAY Study Group. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013 Jun;36(6):1758-64.Texto completo  Resumen

114. Bjornstad P, Drews KL, et al; TODAY Study Group. Long-term complications in youth-onset type 2 diabetes. N Engl J Med. 2021 Jul 29;385(5):416-26.Texto completo  Resumen

115. Svensson M, Sundkvist G, Arnqvist HJ, et al. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003 Oct;26(10):2903-9.Texto completo  Resumen

116. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care. 2007 Oct;30(10):2593-8.Texto completo  Resumen

117. Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018 Mar;137:231-41. Resumen

118. Khader YS, Dauod AS, El-Qaderi SS, et al. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications. 2006 Jan-Feb;20(1):59-68. Resumen

119. Shaw JE, Punjabi NM, Wilding JP, et al. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008 Jul;81(1):2-12. Resumen

120. Ke C, Lau E, Shah BR, et al. Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study. Ann Intern Med. 2019 Feb 5;170(3):145-54. Resumen

121. Betts P, Brink SJ, Swift PG, et al. Management of children with diabetes requiring surgery. Pediatr Diabetes. 2007 Aug;8(4):242-7. Resumen

122. Springer SC, Silverstein J, Copeland K, et al; American Academy of Pediatrics. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics. 2013 Feb;131(2):e648-64.Texto completo  Resumen